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Background. Choledochal cysts are uncommon biliary lesions. Due to the evolution of imaging and laparoscopic surgery, we
sought to describe our last 3 years experience with the presentation and management of choledochal cysts in adults. Methods.
A retrospective review of a prospectively established database of adults who were managed for primary choledochal cyst disease
between 2005 and 2008 was performed. Results. Between 8/2005 and 8/2008, 14 adults were managed for primary choledochal cyst
disease. The average age was 41 years (range 17–86) and 79% were female. Presentations included biliary sepsis (3), pancreatitis
(2), abdominal pain (3), or painless jaundice (1). Three patients had the cyst found during laparoscopic cholecystectomy, and
two had an incidental ﬁnding after CT scan for an unrelated issue. The length of stay for those who had the cyst removed was
7.8 days (range 5–11). There were no operative or post-operative complications. Conclusions. Over the last 3 years 36% of our
patients with choledochal cysts presented after incidental ﬁnding, either during a laparoscopic operation or after a CT scan for an
unrelated problem. Increasing utilization of laparoscopy and CT scan for abdominal complaints has lead to a change in the pattern
of presentation.
Copyright © 2009 Rajeev Dhupar et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Background
Choledochal cysts (CDCs) are uncommon, yet well doc-
umented congenital dilations of the intra- and/or extra-
hepatic biliary tree that can carry signiﬁcant morbidity if
not recognized and treated early [1]. Traditionally, there
are ﬁve varieties of CDCs that are classiﬁed according to
their location in the biliary tree by the Todani modiﬁcation
of the Alonso-Lej classiﬁcation [2]. Classically, this disease
has been described to have a higher incidence of diagnosis
during the ﬁrst decade of life as well as a predominance
in females of 3-4:1 [3–5]. Additionally, there is a much
higherprevalenceofCDCsinsoutheastAsiancountries,with
an overall incidence of 1:1000 compared with 1:100 000–
150 000 in Western countries. An unexplained phenomena,
however, is that Asian immigrants to Western countries do
not carry the high incidence present in their native countries
[1, 4, 6]. CDCs are associated with the congenital biliary
anomaly pancreaticobiliary maljunction (PBM) as well as a
higher lifetime risk for the development of cholangitis, acute
pancreatitis, and cholangiocarcinoma; therefore, immediate
excision or liver transplantation is recommended [1, 4, 7–
11]. However, because of the relatively rare presentation
of this disease in western countries, much of the current
understanding of the presentation and management is
derived from large Asian series [3].
Recently, Edil et al. reported the largest single institution
western experience with CDC management and concluded
that surgical intervention greatly reduces or perhaps elim-
inates the risk of cholangiocarcinoma [9]. Additionally,
while conﬁrming the need for excision of CDCs to prevent
associated morbidity, this and multiple other reports have
suggested that the most common presentation of this disease
in adults is rarely the classically described “triad” of right
upper quadrant pain, jaundice, and palpable abdominal
mass.Instead,thesereportssuggestthatadultsaremostlikely
to present with abdominal pain, are much less likely to have
jaundice, and rarely if ever have an abdominal mass [1, 9,
12, 13]. While these studies cover a large number of patients,
they also span a long period of time, some up to 30 years [1,
8, 9, 12]. While valuable in helping us understand the long-
term outcomes associated with surgical management, they2 HPB Surgery
Table 1: Demographic information of all patients including age, gender, presentation, type of cyst, operation, and presence of malignancy
on initial pathology.
Patient Age Sex Cyst type (Todani) Presentation Operation Malignancy at operation
12 4 F I Incidental Roux-en-y hepatico J
a No
22 4 F I V Incidental R lobectomy, hepatico J No
34 9 F I Abdominal pain Roux-en-y-hepatico J No
44 1 F V Incidental R lobectomy No
56 2 F I Incidental Roux-en-y-hepatico J No
61 9 F I Abdominal pain Roux-en-y-hepatico J No
71 7 F I Incidental Roux-en-y hepatico J No
84 1 F I Jaundice Roux-en-y-hepatico J No
92 2 F I Abdominal pain/
pancreatitis Roux-en-y-hepatico J No
10 17 F I Pancreatitis Roux-en-y-hepatico J No
11 44 F III Abdominal pain (post
cholecystectomy) Whipple No
12 68 M II Biliary sepsis Laparoscopic
cholecystectomy
Yes (HCC)
b
13 86 M V Biliary sepsis Ll o b e c t o m y ,r e m o v a l
impacted stone
No
14 65 M I Biliary sepsis Roux-en-y-hepatico J No
a: hepaticojejunostomy; b: hepatocellular carcinoma.
do not describe how the presentation of CDCs has changed
with the evolution of medicine and technology. Over the
last few decades there have been advances in the ﬁeld of
radiology that signiﬁcantly impact how many diseases are
diagnosed and ultimately managed. We therefore undertook
a study of our recent experience with CDCs in adults in
order to determine if the evolution of medical technology
has changed the presentation, management, or short term
outcomes of CDC disease from what is described in reported
series that span a much broader time period. Here we
report 14 patients over 3 years that were diagnosed with
CDCs at a single institution and describe the presentation,
management, and outcomes of these patients.
2. Methods
Approval for this study was obtained from the Institutional
Review Board. A search for “choledochal cyst” was per-
formed for all patients receiving an operation at the UPMC
Liver Cancer Canter between 2005 and 2008. We analyzed
patient demographics, presentation, type of cyst, pathology,
operation,andcomplications.Aseriesof14patientswiththe
above criteria was found and all were included in the study.
3. Results
3.1. Patient Demographics and Presentation. Fourteen adults
were managed for primary CDC disease over a three year
period. The average age was 41 years (range 17–86) and 79%
were female. The median age for the women was 24 years
(range 17–62), while the median age for the men was 68
years (range 65–86). All three men presented with biliary
sepsis, while the women presented with either pancreatitis
(2), abdominal pain (3), painless jaundice (1), incidental
ﬁnding during visual inspection or cholangiogram during
laparoscopic cholecystectomy (3), or incidental ﬁnding after
CT scan for an unrelated issue (2) (Tables 1 and 2).
3.2. Diagnosis, Management and Outcomes. Fifty-eight per-
cent of the patients had an ERCP, 29% had MRCP only,
and no patients were diagnosed or further evaluated by
ultrasound. Nine patients had a Todani type I cyst, 1 had a
type II cyst, 1 had a type III cyst, 1 had a type IV cyst, and 2
h a datyp eVc y s t( Table 1). The presence of pancreaticobiliar
maljunction was not discerned in these patients, as all would
undergo operative intervention that would excise the CDC
and undergo biliary diversion. All patients with type I cysts
had excision with a Roux-en-Y hepaticojejunostomy. The
patient with a type III cyst had a Whipple procedure because
the patient had persistent symptoms of pain and nausea
despite endoscopic sphincterotomy, and the cyst involved
the pancreatic duct extending into the pancreatic head. The
patients with types IV and V cysts had hepatic lobectomies
appropriate for the extent of disease with or without Roux-
en-Y reconstruction. The patient with a type II cyst did not
have it removed because of decompensated liver cirrhosis
and was found after laparoscopic cholecystectomy to have
biopsy proven hepatocellular carcinoma (Table 1). The aver-
age length of stay for those who had the cyst removed was 7.8
days (range 5–11). There were no operative or postoperative
complications. All pathology has revealed benign disease,
and all patients have had an uneventful followup.HPB Surgery 3
4. Discussion
EarlydetectionandtreatmentofCDCsisanimportantfactor
in the overall lifetime occurrence of cholangiocarcinoma.
The lifetime risk of CDC associated cholangiocarcinoma is
as high as 26% in some studies, and importantly, the rate of
occurrence increases with age [1, 8, 13–15]. Patients discov-
ered in their twenties have only a 2.3% risk of concomitant
malignancy, but this increases to 75% in patients with CDCs
discovered in their eighties [1, 8, 13–15]. Once found, the
current treatment of choice is surgical excision, as it is well
documented to lead to a decrease in rate of malignancy from
16% to less than 1% [7, 9, 14].
CDCs are also associated with another rare congenital
biliary anomaly, pancreaticobiliary malformation (PBM).
PBM is the extraduodenal fusion of the pancreatic duct and
common bile duct beyond the sphincter of Oddi, and while
found in a high proportion of patients with type I CDCs,
they are thought to be distinct embryologic and clinical
entities [10]. In our series, while 64% of the patients had
type I CDCs, it was not speciﬁcally noted if PBM was present
as well. While the ultimate management of these patients
may not have been diﬀerent, the association of PBM with
CDC merits study, as this relationship provides a potential
pathogenesis for the causes of the morbidity that underlies
CDCs, including cholangiocarcinoma [10, 16].
TreatmentofCDCspriortotheonsetofsymptomsisrec-
ommended, as the beneﬁt of reducing the risk of cholangio-
carcinomaoutweighstheriskofsurgerypriortothedevelop-
ment of symptoms [12]. Recently, Lipsett et al. reported that
whiletheratioofincidenceofCDCsinadultsversuschildren
was1:1threedecadesago,ithasrisentoalmost4:1[12,13].
When these adults present, it is usually with the chief com-
plaint of abdominal pain, and rarely do adults with CDCs
have jaundice or an abdominal mass [1, 9, 12, 13]. However,
the symptoms are not pathognomonic and the classically
described triad of abdominal pain, jaundice, and palpable
mass is more the exception than the rule [5, 6, 9, 17].
Historically, management of CDCs consisted of vari-
ous drainage operations, but high complication rates and
retained threat of malignancy have led to the use of excision
or transplantation as ﬁrst-line therapy [5, 18]. The preferred
surgical operation is cyst removal and Roux-en-y hepaticoje-
junostomy, and depending on cyst type (Todani type IV, V),
further intervention may be necessary [2, 4, 12, 18]. All of
our patients, whether symptomatic or asymptomatic, were
treated with surgical excision. If intrahepatic involvement
was present, hepatic lobectomy was performed. Fortunately,
although CDCs associated cholangiocarcinoma are generally
foundin11%ofcases,it wasnot foundinanyofourpatients
[1, 8, 13–15]. This may lie partly in the fact that the risk
of CDC associated cholangiocarcinoma increases with age,
and the average age of our patients was 41 years. Only 3
of our patients were over age 65, and one had associated
HCC. However, it is likely that with increased numbers of
patients the rate of cholangiocarcinoma will meet what is
found in the broader population. Unfortunately, due to the
short followup in this study of patients recently diagnosed
and treated for CDC, it is not yet possible to evaluate and
Table 2: Presentation of choledochal cyst, number of patients with
each presentation, and the percentage with each presentation.
Presentation n %
Biliary Sepsis 3 21
Pancreatitis 2 14
Abdominal Pain 3 21
Jaundice 1 7
Incidental Presentation 5 36
-CT scan 21 4
-Cholangiogram 21 4
-visual inspection during elective operation 17
comparelong-termoutcomesfromnontraditionaldiscovery.
Generally, our followup in patients without malignancy
consistsofyearlyLFTsandevaluationfornewsymptoms,but
not yearly imaging.
As medicine and medical technology have evolved, so
has the presentation of CDCs at our institution. In the
last decade there have been signiﬁcant improvements in the
quality of medical imaging technology as well as greater
access and utilization of more sophisticated imaging devices
such as CT scanners. Additionally, the more widespread
use of minimally invasive surgery has made it possible for
procedures to be diagnostic as well as therapeutic and has
obviatedtheneedtoundertakeanunplannedlargeoperation
and instead refer patients to appropriate specialists. In our
series, while the majority of patients presented symptomat-
ically, 36% seen at our center over three years presented
with asymptomatic CDCs. Two patients had CDCs found
by CT scan, one for left upper quadrant pain and one
for pelvic pain from a ruptured ovarian cyst. Three were
found during laparoscopic cholecystectomy for acalculous
or chronic cholecystitis. These patients were not found to
have choledochal lithiasis and did not have the choledochal
cystidentiﬁedonultrasoundexaminationduringtheirinitial
work-up. It can be presumed that the CDCs were missed on
the ultrasounds, however this cannot be conﬁrmed. One was
a type I cyst seen on inspection during the cholecystectomy,
o n ew a sat y p eI Vc y s ts e e no nc h o l a n g i o g r a m ,a n do n ew a s
a type V cyst seen on cholangiogram (Table 2). For those
patients that did present with symptoms, most presented
withabdominalpain(21%),andfewpresentedwithjaundice
(7%) or abdominal masses (0%), which is in agreement
with ﬁndings from the previous reports [1, 9, 12, 13].
Additionally, the characteristics of our patients match what
is commonly reported in western adult populations, with a
female to male ratio of roughly 4 : 1 and a majority being
Todani Type I (64%) [1, 9, 12, 13].
Choledochal cysts, an uncommon malformation of the
biliary tree, can lead to signiﬁcant morbidity and mortality
if not treated promptly [4, 9]. Traditionally regarded as
a disease of childhood, over the last two decades many
reports are ﬁnding a higher percentage of patients with
CDCs presenting as adults [6, 12, 13]. In addition, we report
that a signiﬁcant percentage of CDCs may now present
without abdominal pain, but rather as an incidental ﬁnding
on CT scan, cholangiogram, or laparoscopic surgery. At4 HPB Surgery
our institution over the last 3 years, more than 1/3 of
the CDCs have presented through nontraditional routes
of diagnosis. While the most common presentation for
CDCs is still abdominal pain, centers may soon recognize
that a signiﬁcant portion of patients with this disease
present incidentally. This may impact not only on the future
risk of developing cholangiocarcinoma, but diagnosis and
treatment prior to onset of symptoms may allow for an
elective resection that avoids postoperative complications.
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